The 2024 forecast indicates that Brazil and Japan lead in female breast malignant neoplasm mortality, with notable year-on-year increases in Brazil and a significant forecasted rise for Peru. The United Kingdom and Mexico also show mild yearly increases, while many European countries like Sweden, Switzerland, and Slovenia exhibit a decline or stabilization in mortality rates. Strong declines in Switzerland and Slovenia contrast with rising values in South Korea and Peru.
Future trends highlight an increasing divergence between countries with preemptive healthcare and those potentially facing rising cases. Emerging healthcare initiatives and early detection programs could alter the course and influence declining trends in countries with proactive measures.
Top countries in Female Breast Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Brazil | 19,360 | 2023 | +2.3% | +1.95% | View data |
| 2 | 2 Japan | 15,520 | 2023 | +1.35% | +1.15% | View data |
| 3 | 3 United Kingdom | 11,580 | 2023 | +0.29% | +0.11% | View data |
| 4 | 4 Mexico | 8,580 | 2023 | +3.56% | +3.85% | View data |
| 5 | 5 Poland | 7,300 | 2023 | +1.47% | +1.14% | View data |
| 6 | 6 Spain | 6,590 | 2023 | +0.35% | +0.16% | View data |
| 7 | 7 Argentina | 5,870 | 2023 | +0.48% | +0.45% | View data |
| 8 | 8 Canada | 5,370 | 2023 | +0.39% | +0.4% | View data |
| 9 | 9 South Africa | 4,200 | 2023 | +2.02% | +2.05% | View data |
| 10 | 10 Colombia | 4,110 | 2023 | +3.45% | +3.71% | View data |
